In Vivo Pharmacokinetics/Pharmacodynamics of Colistin and Imipenem in Pseudomonas aeruginosa Biofilm Infection
Open Access
- 1 May 2012
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 56 (5), 2683-2690
- https://doi.org/10.1128/aac.06486-11
Abstract
Many Pseudomonas aeruginosa isolates from the airways of patients with cystic fibrosis (CF) are sensitive to antibiotics in susceptibility testing, but eradication of the infection is difficult. The main reason is the biofilm formation in the airways of patients with CF. The pharmacokinetics (PKs) and pharmacodynamics (PDs) of antimicrobials can reliably be used to predict whether antimicrobial regimens will achieve the maximum bactericidal effect against infections. Unfortunately, however, most PK/PD studies of antimicrobials have been done on planktonic cells and very few PK/PD studies have been done on biofilms, partly due to the lack of suitable models in vivo . In the present study, a biofilm lung infection model was developed to provide an objective and quantitative evaluation of the PK/PD profile of antimicrobials. Killing curves were set up to detect the antimicrobial kinetics on planktonic and biofilm P. aeruginosa cells in vivo . Colistin showed concentration-dependent killing, while imipenem showed time-dependent killing on both planktonic and biofilm P. aeruginosa cells in vivo . The parameter best correlated to the elimination of bacteria in lung by colistin was the area under the curve (AUC) versus MIC (AUC/MIC) for planktonic cells or the AUC versus minimal biofilm inhibitory concentration (MBIC; AUC/MBIC) for biofilm cells. The best-correlated parameter for imipenem was the time that the drug concentration was above the MIC for planktonic cells ( T MIC ) or time that the drug concentration was above the MBIC ( T MBIC ) for biofilm cells. However, the AUC/MIC of imipenem showed a better correlation with the efficacy of imipenem for biofilm infections ( R 2 = 0.89) than planktonic cell infections ( R 2 = 0.38). The postantibiotic effect (PAE) of colistin and imipenem was shorter in biofilm infections than planktonic cell infections in this model.This publication has 53 references indexed in Scilit:
- Novel concepts in evaluating antimicrobial therapy for bacterial lung infections in patients with cystic fibrosisJournal of Cystic Fibrosis, 2011
- Pharmacokinetics/Pharmacodynamics of Colistin and Imipenem on Mucoid and Nonmucoid Pseudomonas aeruginosa BiofilmsAntimicrobial Agents and Chemotherapy, 2011
- Role of Extracellular DNA during Biofilm Formation by Listeria monocytogenesApplied and Environmental Microbiology, 2010
- Genetic adaptation of Pseudomonas aeruginosa during chronic lung infection of patients with cystic fibrosis: strong and weak mutators with heterogeneous genetic backgrounds emerge in mucA and/or lasR mutantsMicrobiology, 2010
- Elucidation of the Pharmacokinetic/Pharmacodynamic Determinant of Colistin Activity against Pseudomonas aeruginosa in Murine Thigh and Lung Infection ModelsAntimicrobial Agents and Chemotherapy, 2010
- Plectasin Shows Intracellular Activity against Staphylococcus aureus in Human THP-1 Monocytes and in a Mouse Peritonitis ModelAntimicrobial Agents and Chemotherapy, 2009
- Azithromycin Blocks Quorum Sensing and Alginate Polymer Formation and Increases the Sensitivity to Serum and Stationary-Growth-Phase Killing ofPseudomonas aeruginosaand Attenuates ChronicP. aeruginosaLung Infection inCftr−/−MiceAntimicrobial Agents and Chemotherapy, 2007
- Differentiation and Distribution of Colistin- and Sodium Dodecyl Sulfate-Tolerant Cells inPseudomonas aeruginosaBiofilmsJournal of Bacteriology, 2007
- Community structure and metabolism through reconstruction of microbial genomes from the environmentNature, 2004
- Kinetics of antimicrobial activityThe Journal of Pediatrics, 1986